HomeAI · summaries
Storia in 6 fonti
New drug a ‘promising step forward’ for hard-to-treat lung cancer
Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung cancer
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Akeso, Summit drug extends survival in closely watched lung cancer trial
Ivonescimab reduced the risk of death by one-third compared to chemotherapy in a China-based study that’s seen as an important barometer for a class of cancer immunotherapies…
- ·
statnews.com
Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.
